| 000 | 01662 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517053441.0 | ||
| 264 | 0 | _c20160913 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.01326-15 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSmith, Robert A | |
| 245 | 0 | 0 |
_aThe Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cDec 2015 |
||
| 300 |
_a7437-46 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xpharmacology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aDrug Resistance, Viral _xgenetics |
| 650 | 0 | 4 |
_aHIV Reverse Transcriptase _xgenetics |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 |
_aHIV-2 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMutagenesis, Site-Directed |
| 650 | 0 | 4 | _aProtein Conformation |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aStavudine _xpharmacology |
| 650 | 0 | 4 |
_aThymidine _xanalogs & derivatives |
| 700 | 1 | _aRaugi, Dana N | |
| 700 | 1 | _aWu, Vincent H | |
| 700 | 1 | _aLeong, Sally S | |
| 700 | 1 | _aParker, Kate M | |
| 700 | 1 | _aOakes, Mariah K | |
| 700 | 1 | _aSow, Papa Salif | |
| 700 | 1 | _aBa, Selly | |
| 700 | 1 | _aSeydi, Moussa | |
| 700 | 1 | _aGottlieb, Geoffrey S | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 59 _gno. 12 _gp. 7437-46 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.01326-15 _zAvailable from publisher's website |
| 999 |
_c25282468 _d25282468 |
||